Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
12/30/2009 | WO2009157219A1 Method of electrochemically detecting nucleic acid with the use of dna conjugate |
12/30/2009 | WO2009157214A1 Spherical non-crystalline magnesium aluminosilicate |
12/30/2009 | WO2009157173A1 Percutaneous absorption enhancer and transdermal preparation using the same |
12/30/2009 | WO2009156991A2 Glycerophospholipids for the improvement of cognitive functions |
12/30/2009 | WO2009156691A2 Novel inverse latices that are free of oxyethylene derivatives, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same |
12/30/2009 | WO2009156690A2 Novel inverse latices based on fatty alcohol ethers, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same |
12/30/2009 | WO2009156679A1 Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid |
12/30/2009 | WO2009156677A2 Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative |
12/30/2009 | WO2009156676A1 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative |
12/30/2009 | WO2009156675A2 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative and a retinoid |
12/30/2009 | WO2009156544A1 Complexes of albumin with omega-9 monounsaturated fatty acids for treatment of medullary lesions |
12/30/2009 | WO2009156481A1 Pegylated bnp |
12/30/2009 | WO2009156466A1 Pharmaceutical compositions for the treatment of neurodegenerative diseases |
12/30/2009 | WO2009156369A1 Pharmaceutical transdermal compositions and method for treating inflammation in cattle |
12/30/2009 | WO2009156161A1 Pharmaceutical compositions comprising aminoadamantane derivatives |
12/30/2009 | WO2009156160A1 Pharmaceutical compositions comprising a complex of aminocyclohexane derivatives and cyclodextrin |
12/30/2009 | WO2009155931A1 Acetic acid and a buffer |
12/30/2009 | WO2009155705A1 Polysaccharide-protein conjugates reversibly coupled via imine bonds |
12/30/2009 | WO2009155689A1 Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections |
12/30/2009 | WO2009127072A8 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
12/30/2009 | WO2009121038A3 Shaped films of hydrogels fabricated using templates of patterned paper |
12/30/2009 | WO2009073809A3 Carbohydrate conjugates as delivery agents for oligonucleotides |
12/30/2009 | WO2009073546A3 Monoclonal antibody partner molecule conjugates directed to protein tyrosine kinase 7 (ptk7) |
12/30/2009 | WO2009023742A3 Spore displaying antigens |
12/30/2009 | WO2008157824A3 Thrombopoietin peptide conjugates |
12/30/2009 | WO2008157624A3 Lactose reduced milk |
12/30/2009 | WO2008089258A3 Drug eluting medical device using polymeric therapeutics |
12/30/2009 | WO2008089256A3 Polymeric therapeutics |
12/30/2009 | EP2138575A1 Conjugates comprising a biodegradable polymer and uses therefor |
12/30/2009 | EP2138192A1 Agent for enhancing the resistance of liposome against biological component, and liposome modified with the agent |
12/30/2009 | EP2138191A1 Enhanced transport using membrane disruptive agents |
12/30/2009 | EP2138190A2 Compositions comprising dietary fat complexer and methods for their use |
12/30/2009 | EP2138166A1 Process for production of tablet |
12/30/2009 | EP2137298A1 Improved three-dimensional biocompatible skeleton structure containing nanoparticles |
12/30/2009 | EP2136828A1 Pharmaceutical composition with antifungal activity containing cymbopogon nardus, its process, and use |
12/30/2009 | EP2136782A1 Ophthalmic oil-in-water emulsions containing prostaglandins |
12/30/2009 | EP2136781A1 Mucosal bioadhesive slow release carrier for delivering active principles |
12/30/2009 | EP2136778A2 Growth factor mediated cosmeceuticals and use thereof to enhance skin quality |
12/30/2009 | EP2136620A2 Methods and compositions for targeting afap |
12/30/2009 | EP2049566B1 G-csf site-specific mono-conjugates |
12/30/2009 | EP1727532B1 Chemically stable compositions of 4-hydroxy tamoxifen |
12/30/2009 | EP1701701B1 Methods of preparing a foam comprising a sclerosing agent |
12/30/2009 | EP1689426B1 Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof |
12/30/2009 | EP1532149B1 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
12/30/2009 | EP1409482B1 Dye-sulfenates for dual phototherapy |
12/30/2009 | EP1309327B1 Pharmaceutical compositions of estrogenic agents |
12/30/2009 | EP1242012B1 Improved transdermal contraceptive delivery system and process |
12/30/2009 | EP1126882B1 Stable preparations with hyperforin |
12/30/2009 | EP0804561B1 Regulated transcription of targeted genes and other biological events |
12/30/2009 | CN101616691A Multimeric conjugate |
12/30/2009 | CN101612404A Heat-resisting lyophilized protectant for chicken newcastle disease and chicken infectious bronchitis dual living vaccine |
12/30/2009 | CN100574807C Tree plant oil women's medical sanitary tampon and method of preparing the same |
12/30/2009 | CN100574806C Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof |
12/30/2009 | CN100574805C Therapeutic infusion containing fructose |
12/30/2009 | CN100574801C Liquid growth hormone formulation |
12/30/2009 | CN100574772C Soft capsule containing lutein and its preparation method |
12/30/2009 | CN100574770C Slow releasing micro pill preparation of loosestrife extract and its preparation process |
12/30/2009 | CN100574760C Camptothecinum-layered thermometal hydroxide nanometer complexes preparation method |
12/30/2009 | CN100574756C Oral preparation having improved bioavailability |
12/30/2009 | CN100574755C Hot melt transcutaneous therapeutic system for administering D2 accelerator |
12/30/2009 | CN100574750C Rapidly-disintegrating formulation for releasing active ingredients |
12/30/2009 | CN100574748C Releasing control piece of time-selecting releasing osmotic pump |
12/30/2009 | CA2729139A1 Octreotide implant having a release agent |
12/30/2009 | CA2729100A1 Methods for dosing an activin-actriia antagonist and monitoring of treated patients |
12/30/2009 | CA2729098A1 Antagonists of activin-actriia and uses for increasing red blood cell levels |
12/30/2009 | CA2729096A1 Methods for dosing an actriib antagonist and monitoring of treated patients |
12/30/2009 | CA2729093A1 Agent for regenerating tympanic membrane or external auditory canal |
12/30/2009 | CA2729054A1 Antagonists of actriib and uses for increasing red blood cell levels |
12/30/2009 | CA2728960A1 Polymer-metal complex composite having mri contrast ability and mri contrasting and/or antitumor composition using the same |
12/30/2009 | CA2728952A1 Percutaneous absorption enhancer and transdermal preparation using the same |
12/30/2009 | CA2728727A1 Pharmaceutical transdermal compositions and method for treating inflammation in cattle |
12/30/2009 | CA2728646A1 Serine glycerophospholipid conjugates and their use in the improvement of cognitive functions |
12/30/2009 | CA2728502A1 Liquid composition of cisplatin coordination compound |
12/30/2009 | CA2728456A1 Acetic acid and a buffer |
12/30/2009 | CA2728000A1 Polysaccharide-protein conjugates reversibly coupled via imine bonds |
12/30/2009 | CA2727726A1 Transdermal delivery apparatus and method |
12/30/2009 | CA2726894A1 Therapeutic agents comprising elastin-like peptides |
12/30/2009 | CA2723435A1 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative and a retinoid |
12/30/2009 | CA2723342A1 Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative |
12/30/2009 | CA2723341A1 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative |
12/30/2009 | CA2723313A1 Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid |
12/30/2009 | CA2722147A1 Pharmaceutical compositions comprising aminocyclohexane derivatives |
12/29/2009 | US7638599 Enhance uptake of a pharmaceutically active agent into a cell, into or out of an intracellular compartment, and across a cell layer either directly or from a pharmaceutically active agent loaded particle; drug delivery |
12/29/2009 | US7638598 ErbB interface peptidomimetics and methods of use thereof |
12/29/2009 | US7638558 Polymeric micelles for drug delivery |
12/29/2009 | US7638144 Composition, apparatus and method for skin rejuvenation |
12/29/2009 | US7638143 Fluidized bed granulation, compression to form tablets |
12/29/2009 | US7638127 Peptide conjugated anti-cancer prodrugs |
12/29/2009 | US7638116 Polyglycerol dimer polyester resins |
12/29/2009 | US7638081 Injection molding process for the preparation of an oral delivery device for a pharmaceutically active agent |
12/29/2009 | CA2484164C Androgen pharmaceutical composition and method for treating depression |
12/29/2009 | CA2468703C Controlled release polymeric compositions of bone growth promoting compounds |
12/29/2009 | CA2465349C Transdermal drug for the treatment of neural paralysis and dysfunction |
12/29/2009 | CA2448140C Superabsorbents, preparation thereof and use thereof |
12/29/2009 | CA2447521C Delivery of antihistamines through an inhalation route |
12/29/2009 | CA2446798C Solid pharmaceutical compositions comprising cyclosporin |
12/29/2009 | CA2422871C Stable solid dosage forms of amino acids and processes for producing same |
12/29/2009 | CA2412575C Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone |
12/29/2009 | CA2384624C Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
12/29/2009 | CA2367507C Angiogenesis using three-dimensional stromal tissue constructs |